Renacon Pharma
Renacon Pharma Limited, founded 1996 in Lahore, Pakistan, manufactures hemodialysis concentrates (liquid and powder), citrate concentrate, disinfectants, and disposables. The Treet Corporation subsidiary sells B2B to dialysis centers and hospitals in domestic and international markets.
- Company typePrivate
- Founded1996
- HeadquartersLahore, Pakistan
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Renacon Pharma does
Renacon Pharma Limited is a Lahore, Pakistan-based specialty pharmaceutical manufacturer of hemodialysis products, founded in 1996 and operating as a wholly-owned subsidiary of Treet Corporation. The company produces hemodialysis concentrates in both solution and powder forms, alongside citrate concentrate, disinfectants, and disposable accessories used by dialysis service providers. Its core technology is the formulation and manufacture of dialysate — the chemical solution used in kidney dialysis machines to filter waste from patient blood — with separate product lines addressing both centralized delivery systems and bedside treatment stations.
The company's business model is B2B distribution to dialysis centers, hospitals, and renal care clinics. It does not sell to end patients or consumers; instead, it sells in commercial volumes to institutional healthcare buyers that consume dialysate as a recurring per-treatment consumable. This generates a usage-driven, replenishment-style revenue mechanic tied to dialysis session counts at customer facilities rather than to discrete equipment sales.
Renacon operates with a headcount of 51–100 employees, indicative of a mid-sized specialty pharma operation rather than a mass-market generics player. As a Treet Corporation subsidiary, it is supported by a larger Pakistani conglomerate parent, though standalone financial disclosure is not available. The company has signaled international ambitions through trade-show participation such as WHX Dubai 2026 (February 9–12, 2026), targeting export markets across the Middle East and South Asia. No AI/ML capabilities, regulatory certifications, named management, or audited financials are disclosed in the available input.
Renacon Pharma firmographics
Firmographics- Name
- Renacon Pharma
- Legal name
- Renacon Pharma Limited
- Website
- https://renaconpharma.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Renacon Pharma Limited, founded 1996 in Lahore, Pakistan, manufactures hemodialysis concentrates (liquid and powder), citrate concentrate, disinfectants, and disposables. The Treet Corporation subsidiary sells B2B to dialysis centers and hospitals in domestic and international markets.
- Ownership category
- akta.pro rank
Renacon Pharma industry classification
Industry- Product category
- Hemodialysis Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges) (HLAHAKAH)
Keywords
Where Renacon Pharma is headquartered
LocationHeadquarters
- HQ city
- Lahore
- HQ country
- Pakistan
- HQ region
- Asia
Offices1 record
Markets served
Renacon Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Hemodialysis Concentrates Sales: Manufacturing and sale of hemodialysis concentrates in solution and powder forms to dialysis centers and healthcare facilities
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Renacon Pharma product offering
Product offeringCore offering
Renacon Pharma Limited manufactures high-quality hemodialysis concentrates in both solution and powder forms for use in dialysis treatment of patients with kidney disease. The company also produces supporting products including specialized citrate concentrate, disinfectants, and disposable supplies used in dialysis procedures, selling primarily to dialysis centers and hospital dialysis units.
Product overview
Renacon Pharma Limited is a single-product-focus pharmaceutical manufacturer specializing in hemodialysis care solutions. The company's portfolio consists of four interconnected product lines: Hemodialysis Concentrates (the core offering, available in solution and powder forms), Citrate Concentrate (a specialized formulation variant), Disinfectants (supporting hygiene in dialysis settings), and Disposables (single-use supplies for dialysis procedures). All products are designed to serve the hemodialysis treatment market, with R&D efforts focused on advanced mixing processes and tailored formulations for cost-effective, high-quality dialysis care.
Differentiator
Problem solved
Functional benefit
Products and services
- Hemodialysis Concentrates High-quality hemodialysis concentrates available in both solution and powder forms, used in dialysis treatment for individuals with kidney disease. Sold to dialysis centers and hospitals.
- Citrate Concentrate
Companies that use Renacon Pharma
Customer profileSegments2 records
Ideal customer profiles1 record
Renacon Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Renacon Pharma partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights2 records
Renacon Pharma competitors and assessment
Company assessmentDirect peers
- Terumo Corporation: Japanese medical technology company with a renal product portfolio including dialysis machines and disposable blood circuits, overlapping with Renacon's disposable and concentrate offerings to dialysis units.
- Asahi Kasei Medical: Subsidiary of Asahi Kasei producing dialyzers and related dialysis products. Comparable focus on renal replacement consumables for chronic kidney disease treatment.
- B. Braun: German medical device and pharmaceutical manufacturer with a significant hemodialysis solutions business, supplying concentrates and dialysis disposables to healthcare facilities globally — closely comparable product breadth to Renacon.
- Baxter International: Multinational manufacturer of dialysate solutions and PD systems. Baxter's home-dialysis and in-center dialysate portfolios directly overlap with Renacon's hemodialysis concentrate offerings to hospitals and dialysis centers.
- Rockwell Medical: US-based specialty pharma manufacturer focused on hemodialysis concentrates and ancillary renal products. Pure-play comparability to Renacon's single-therapeutic-focus concentrate manufacturing model.
- Fresenius Medical Care: Global market leader in dialysis products and services. Fresenius manufactures dialysate concentrates and operates the largest dialysis clinic network, making it the dominant direct competitor to Renacon in the hemodialysis consumables category.
- Nipro Corporation: Japanese medical device and pharmaceutical company manufacturing dialyzers, bloodlines and dialysis fluids. Comparable in offering a vertically integrated bundle of dialysis consumables to renal centers.
Broad incumbents
- Diaverum: Global dialysis service provider operating centers across Europe, Latin America, the Middle East and Asia. Acts as a high-value buyer of hemodialysis consumables and a potential channel partner for Renacon's export ambitions in MENA.
- DaVita: Largest US dialysis services operator and a major buyer of dialysate concentrates. While DaVita is primarily a service provider rather than manufacturer, it represents Renacon's downstream customer archetype and a key channel for any future expansion into clinic-owned supply.
Emerging players
- JMS Co., Ltd. Japanese medical device manufacturer with a dialysis product line including dialyzers and blood tubing sets. Comparable in being an Asia-based, mid-sized specialist competing against multinational incumbents in regional markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Renacon Pharma social profiles
Digital presenceRenacon Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Renacon Pharma leadership team
Management profileNumber of profiles
Renacon Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Renacon Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Renacon Pharma
What does Renacon Pharma do?
Renacon Pharma Limited manufactures high-quality hemodialysis concentrates in both solution and powder forms for use in dialysis treatment of patients with kidney disease. The company also produces supporting products including specialized citrate concentrate, disinfectants, and disposable supplies used in dialysis procedures, selling primarily to dialysis centers and hospital dialysis units.
Is Renacon Pharma a public or private company?
Renacon Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Renacon Pharma founded?
Renacon Pharma was founded in 1996. It employs 51 to 100 people.
Where is Renacon Pharma based?
Renacon Pharma is headquartered in Lahore, Pakistan, in the Asia region.
How does Renacon Pharma make money?
One revenue line is on record: hemodialysis Concentrates Sales.
Who are Renacon Pharma's main competitors?
Direct peers on record are Terumo Corporation, Asahi Kasei Medical, B. Braun, Baxter International, Rockwell Medical, Fresenius Medical Care and Nipro Corporation. Broad incumbents are Diaverum and DaVita. JMS Co., Ltd. is listed as an emerging player.
Does Renacon Pharma have an API?
No public API is recorded for Renacon Pharma.
What industry is Renacon Pharma in?
Renacon Pharma's product category is Hemodialysis Pharmaceuticals. Its primary akta.pro industry code is HLAHAKAH, Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges). Its NAICS code is 325412 and its SIC code is 2834.